Yusop, Mia T.
HRN: 15 52 20 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/27/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/27/2023
07/03/2023
IV
600mg
Q8
UTI; Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Urinary TractSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes